Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Docteur Sophie Leflot - Néphrologie from Namur, company number BE0787397993, closed financial year 2025 with a result of € 132,492 after tax. For that financial year Docteur Sophie Leflot - Néphrologie recorded a gross margin of € 170,223 and equity of € 270,798. Compared with financial year 2024, the result moved from € 150,210 to € 132,492. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
€ 270,798
▲ 20% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 132,492
▼ 12% vs 2024
Profit after tax over the fiscal year.
€ 226,209
▲ 60% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 100,000 paid out
75 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 973
▼ 30% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 136
▼ 93% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 32,925
▲ 16% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 116,782 | € 198,572 | € 170,223 | ▼ 14% |
| Profit after taxes | € 89,095 | € 150,210 | € 132,492 | ▼ 12% |
| Equity | € 81,095 | € 225,306 | € 270,798 | ▲ 20% |
| Total debts | € 35,862 | € 41,441 | € 133,061 | ▲ 221% |
| Cash | € 46,674 | € 140,984 | € 226,209 | ▲ 60% |
| Retained profit | € 79,095 | € 223,306 | € 255,798 | ▲ 15% |
| Dividend | € 10,000 | € 6,000 | € 100,000 | ▲ € 94,000 |
| Bank debt | € 1,015 | € 0 | € 0 | |
| Balance sheet total | € 116,957 | € 266,747 | € 403,858 | ▲ 51% |
Key figures of Docteur Sophie Leflot - Néphrologie, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Docteur Sophie Leflot - Néphrologie?
What happened at Docteur Sophie Leflot - Néphrologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 132,492 (▼ 12% vs 2024). Source: NBB ↗
- New establishment in Namur. KBO
- Sophie Leflot became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 89,095 profit in 2023 to € 132,492 profit in 2025.
Paid € 110,118 in corporate taxes since 2023.
Best year ever: 2024, with € 150,210 profit.
Paid out € 116,000 in dividends to the owners in total.
A new publication or filing at Docteur Sophie Leflot - Néphrologie? We notify you, reason included.
Follow Docteur Sophie Leflot - NéphrologieDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Docteur Sophie Leflot - Néphrologie is Sophie Leflot.
Directors
According to the 2025 annual accounts
Sophie Leflot
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Chemin du Bienvenu(WP) 3
5100 Namur
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0787.397.993
- VAT number
- BE 0787.397.993
- Registered office
- Chemin du Bienvenu(WP) 3, 5100 Namur
- Names & denominations
- Docteur Sophie Leflot - Néphrologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 June 2022
- Peppol
- Not registered